Search - tctmd.com

Displaying 861 - 880 of 1192

Sort: Relevancy | Date

News Conference News TCT 2014

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

September 15, 2014

Presentation TCT 2014

Ischemia and Clinical Outcomes: The Missing Mechanistic Link

Presenter: Bernard De Bruyne, Manesh R. Patel, Allen Jeremias

September 14, 2014

Presentation TCT 2014

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Karl-Ludwig Schulte

September 14, 2014

News Conference News TCT 2014

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

September 14, 2014

News Conference News TCT 2014

PERFECT-LUTS: Endovascular Revascularization Shows Promise for Patients with ED, Lower Urinary Tract Symptoms

Yael L. Maxwell

September 14, 2014

News Conference News TCT 2014

OCT STEMI: Imaging-Guided PCI Shows Promise

September 14, 2014

News Industry News

New Study Assesses the Utility of Optical Coherence Tomography During Stent Implantation in Primary PCI

September 14, 2014

News Industry News

First of Its Kind Study Compares Outcomes of Fractional Flow Reserve-Guided and Angiography-Guided Provisional Side Branch Stenting

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

News Conference News TCT 2014

ABSORB EXTEND: BVS Safe Out to 3 Years

September 14, 2014

News Industry News

Large Randomized Trial Compares Use of Vascular Closure Devices to Manual Compression in Patients Undergoing Transfemoral Coronary Angiography

September 13, 2014

News Daily News

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

L.A. McKeown

September 11, 2014

News Daily News

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

September 11, 2014

News Daily News

Initial Thrombolysis Found to Be the Most Costly Strategy for Acute Limb Ischemia

September 08, 2014

News Conference News ESC 2014

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

Caitlin E. Cox

September 03, 2014

News Industry News

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

September 02, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Conference News ESC 2014

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Todd Neale

September 01, 2014

News Conference News ESC 2014

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

Caitlin E. Cox

September 01, 2014

Advertisement

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

Ischemia and Clinical Outcomes: The Missing Mechanistic Link

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

PERFECT-LUTS: Endovascular Revascularization Shows Promise for Patients with ED, Lower Urinary Tract Symptoms

OCT STEMI: Imaging-Guided PCI Shows Promise

New Study Assesses the Utility of Optical Coherence Tomography During Stent Implantation in Primary PCI

First of Its Kind Study Compares Outcomes of Fractional Flow Reserve-Guided and Angiography-Guided Provisional Side Branch Stenting

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

ABSORB EXTEND: BVS Safe Out to 3 Years

Large Randomized Trial Compares Use of Vascular Closure Devices to Manual Compression in Patients Undergoing Transfemoral Coronary Angiography

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

Initial Thrombolysis Found to Be the Most Costly Strategy for Acute Limb Ischemia

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content